VistaGen Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity

Source :: Internet Wire. April 25, 2012
Publication Year :: 2012
Abstract: Byline: SOUTH SAN FRANCISCO, CA, Apr 25, 2012 (MARKETWIRE via COMTEX) -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, has [...]

Subjects :: VistaGen Therapeutics Inc. -- Intellectual property
Gene expression -- Methods
Embryonic stem cells -- Methods
Biotechnology industry -- Intellectual property -- Methods
Drugs -- Methods
Liver -- Methods
Patents -- Methods
Cells -- Methods
Pharmaceutical industry -- Intellectual property -- Methods
Patent/copyright issue
Business
Business, international
News, opinion and commentary

Tools